Author

G. D. Tomaras

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 5

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:host-pathogen & immune response· 5 Assay:proteomics· 4 Research Focus:differential expression· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Organism:human· 1

Frequent Co-Authors

B. F. Haynes· 3 shared G. Ferrari· 3 shared D. C. Montefiori· 2 shared D. Goodman· 2 shared K. O. Saunders· 2 shared R. R. Amara· 2 shared S. M. Alam· 2 shared X. Shen· 2 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 26 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

B. F. Haynes

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions

C. N. Pierre, L. E. Adams, K. Anasti, D. Goodman, S. Stanfield-Oakley, J. M. Powers, D. Li, W. Rountree, Y. Wang, R. J. Edwards, S. M. Alam, G. Ferrari, G. D. Tomaras, B. F. Haynes, R. S. Baric, K. Saunders

This study shows non-neutralizing SARS-CoV-2 antibodies protect mice from severe disease via Fc-mediated effector functions, reducing viral load and lung damage.

bioRxiv · Jul 25, 2023Immunology

Tailoring Tfh Profiles Enhances Antibody Persistence to a Clade C HIV-1 Vaccine in Rhesus Macaques

A. Verma, C. E. Hawes, S. R. Elizaldi, J. C. Smith, D. Rajasundaram, G. K. Pedersen, X. Shen, L. D. Williams, G. D. Tomaras, P. A. Kozlowski, R. R. Amara, S. S. Iyer

This study shows that inducing GC Tfh1 cells with MPLA+QS-21 adjuvant leads to higher and longer-lasting HIV-1 Env antibodies in rhesus macaques compared to CAF01.

bioRxiv · Jul 18, 2023 · PreprintImmunology

Changes at V2 apex of HIV-1 Clade C trimer enhance elicitation of autologous neutralizing and broad V1V2-scaffold antibodies

A. Sahoo, E. A. Hodge, C. LaBranche, T. T. Styles, X. Shen, N. Cheedarla, A. Shiferaw, G. Ozorowski, W.-H. Lee, A. B. Ward, G. D. Tomaras, D. C. Montefiori, D. J. Irvine, K. K. Lee, R. R. Amara

bioRxiv · Jun 15, 2021 · PreprintImmunology

Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates

K. O. Saunders, N. Pardi, R. Parks, S. Santra, Z. Mu, L. L. Sutherland, R. Scearce, M. Barr, A. Eaton, G. Hernandez, D. Goodman, M. J. Hogan, I. Tombacz, D. Gordon, R. W. Rountree, , B. F. Haynes

This study compares the immunogenicity of mRNA-LNP vaccines to protein vaccines in nonhuman primates, finding comparable or superior HIV-1 antibody responses.

bioRxiv · Dec 30, 2020Immunology

Boosting with ALVAC-HIV and AIDSVAX B/E enhances Env constant region 1 and 2 antibody-dependent cellular cytotoxicity

D. Easterhoff, J. Pollara, K. Luo, W. D. Tolbert, B. Young, D. Mielke, S. Jha, R. J. O'Connell, S. Vasan, J. Kim, N. Michael, J.-L. Excler, M. L. Robb, S. Rerks-Ngarm, J. Kaewkungwal, , G. Ferrari

The paper shows that boosting RV144 vaccine recipients with ALVAC-HIV and AIDSVAX B/E increases C1C2-specific antibody-dependent cellular cytotoxicity breadth and potency.

bioRxiv · May 9, 2019 · PreprintImmunology